Despite years of intensive research into multiple sclerosis (MS) scientists have not yet succeeded in developing an absolute therapy for the treatment of this disabling disease of the human central nervous system. The wide immunological gap between inbred rodent strains and the heterogeneous human population is probably the single most important factor that hampers the translation of scientific principles developed in rodents into effective therapies for MS. Because of the closer immunological proximity to humans, non-human primates provide useful experimental models that may help to bridge this gap. Here we review the models of experimental autoimmune encephalomyelitis in rhesus macaques and common marmosets. We will discuss the salient po...
Ageing Western societies are facing an increasing prevalence of chronic inflammatory and degenerativ...
Experimental autoimmune encephalomyelitis in the common marmoset, a nonhuman primate species (Callit...
Aging Western societies are facing an increasing prevalence of chronic autoimmune-mediated inflammat...
The many, highly specific, biological therapies for immune-based diseases create a need for valid pr...
Multiple sclerosis (MS) is one of the most intensively studied immune-based inflammatory diseases (I...
The phylogenetic proximity between non-human primate species and humans is reflected by a high degre...
Introduction: The translation of scientific discoveries made in animal models into effective treatme...
textabstractMultiple sclerosis (MS) is a major cause of disability in young adults affecting approxi...
The attrition rate of new drugs for central nervous system diseases including multiple sclerosis (MS...
The efficacy of many new immunomodulatory therapies for multiple sclerosis (MS) patients has often b...
Due to their genetic and immunological proximity to humans, the common marmoset, Callithrix jacchus,...
The experimental autoimmune encephalitis (EAE) model is used for preclinical research into the patho...
The high failure rate of immunotherapies in multiple sclerosis (MS) clinical trials demonstrates pro...
The high failure rate of immunotherapies in multiple sclerosis (MS) clinical trials demonstrates pro...
New drugs often fail in the translation from the rodent experimental autoimmune encephalomyelitis (E...
Ageing Western societies are facing an increasing prevalence of chronic inflammatory and degenerativ...
Experimental autoimmune encephalomyelitis in the common marmoset, a nonhuman primate species (Callit...
Aging Western societies are facing an increasing prevalence of chronic autoimmune-mediated inflammat...
The many, highly specific, biological therapies for immune-based diseases create a need for valid pr...
Multiple sclerosis (MS) is one of the most intensively studied immune-based inflammatory diseases (I...
The phylogenetic proximity between non-human primate species and humans is reflected by a high degre...
Introduction: The translation of scientific discoveries made in animal models into effective treatme...
textabstractMultiple sclerosis (MS) is a major cause of disability in young adults affecting approxi...
The attrition rate of new drugs for central nervous system diseases including multiple sclerosis (MS...
The efficacy of many new immunomodulatory therapies for multiple sclerosis (MS) patients has often b...
Due to their genetic and immunological proximity to humans, the common marmoset, Callithrix jacchus,...
The experimental autoimmune encephalitis (EAE) model is used for preclinical research into the patho...
The high failure rate of immunotherapies in multiple sclerosis (MS) clinical trials demonstrates pro...
The high failure rate of immunotherapies in multiple sclerosis (MS) clinical trials demonstrates pro...
New drugs often fail in the translation from the rodent experimental autoimmune encephalomyelitis (E...
Ageing Western societies are facing an increasing prevalence of chronic inflammatory and degenerativ...
Experimental autoimmune encephalomyelitis in the common marmoset, a nonhuman primate species (Callit...
Aging Western societies are facing an increasing prevalence of chronic autoimmune-mediated inflammat...